Telehealth companies selling low-cost, compounded versions of popular weight-loss drugs, including Ozempic and Wegovy, are drawing increased interest from employers, Bloomberg reported Oct. 29.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
